13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0000950123-24-005128
Total Value
$135.1M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,346,934 | $77.5M | 57.42% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $45.0M | 33.29% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $12.5M | 9.29% |